is wegovy a semaglutide or tirzepatide vs. Ozempic: What To Know What are the main differences – Zepbound versus Wegovy: Which one

PMID 23065655

Three-year efficacy and safety of exenatide once weekly: a pooled analysis of three trials

For injuries and gut repair, the progress often holds

En octubre del 2025 la FDA amplio la indicacin de simaglutida para la reduccin del riesgo de eventos cardiovasculares mayores (muerte cardiovular, infarto al miocardio no fatal, ataque vascular no fatal) en adultos con diabetes mellitus tipo 2 (no insulinodependiente) que tienen riesgo alto de desarrollar estos eventos

This could reflect disruptions in the secretion of proteins that depend on the ER, as well as intracellular depletion of proteins secreted through alternative pathways